| 000 | 01775 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250514164158.0 | ||
| 264 | 0 | _c20040429 | |
| 008 | 200404s 0 0 eng d | ||
| 022 | _a0893-228X | ||
| 024 | 7 |
_a10.1021/tx0340910 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAsk, K | |
| 245 | 0 | 0 |
_aReduction of nilutamide by NO synthases: implications for the adverse effects of this nitroaromatic antiandrogen drug. _h[electronic resource] |
| 260 |
_bChemical research in toxicology _cDec 2003 |
||
| 300 |
_a1547-54 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmines _xchemistry |
| 650 | 0 | 4 | _aAnaerobiosis |
| 650 | 0 | 4 |
_aAndrogen Antagonists _xadverse effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCattle |
| 650 | 0 | 4 | _aElectron Spin Resonance Spectroscopy |
| 650 | 0 | 4 |
_aFree Radicals _xchemistry |
| 650 | 0 | 4 |
_aImidazoles _xadverse effects |
| 650 | 0 | 4 | _aImidazolidines |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNADP _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xgenetics |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type I |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type II |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type III |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aRecombinant Proteins _xgenetics |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aDijols, S | |
| 700 | 1 | _aGiroud, C | |
| 700 | 1 | _aCasse, L | |
| 700 | 1 | _aFrapart, Y-M | |
| 700 | 1 | _aSari, M-A | |
| 700 | 1 | _aKim, K-S | |
| 700 | 1 | _aStuehr, D J | |
| 700 | 1 | _aMansuy, D | |
| 700 | 1 | _aCamus, P | |
| 700 | 1 | _aBoucher, J-L | |
| 773 | 0 |
_tChemical research in toxicology _gvol. 16 _gno. 12 _gp. 1547-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/tx0340910 _zAvailable from publisher's website |
| 999 |
_c14412616 _d14412616 |
||